Global Omalizumab for Injection Market Growth 2022-2028
- LP 4784796
- 71 Pages
- January 2022
- Pharmaceuticals
The United States Omalizumab for Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Omalizumab for Injection market, reaching US$ million by the year 2028. As for the Europe Omalizumab for Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Omalizumab for Injection players cover Roche, Novartis, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Omalizumab for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Subcutaneous Powder For Injection
Subcutaneous Solution (150 mg/mL)
Subcutaneous Solution(75 mg/0.5 mL)
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Roche
Novartis
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Omalizumab for Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Omalizumab for Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Omalizumab for Injection by Country/Region, 2017, 2022 & 2028
2.2 Omalizumab for Injection Segment by Type
2.2.1 Subcutaneous Powder For Injection
2.2.2 Subcutaneous Solution (150 mg/mL)
2.2.3 Subcutaneous Solution(75 mg/0.5 mL)
2.3 Omalizumab for Injection Sales by Type
2.3.1 Global Omalizumab for Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Omalizumab for Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Omalizumab for Injection Sale Price by Type (2017-2022)
2.4 Omalizumab for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Omalizumab for Injection Sales by Application
2.5.1 Global Omalizumab for Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Omalizumab for Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Omalizumab for Injection Sale Price by Application (2017-2022)
3 Global Omalizumab for Injection by Company
3.1 Global Omalizumab for Injection Breakdown Data by Company
3.1.1 Global Omalizumab for Injection Annual Sales by Company (2020-2022)
3.1.2 Global Omalizumab for Injection Sales Market Share by Company (2020-2022)
3.2 Global Omalizumab for Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Omalizumab for Injection Revenue by Company (2020-2022)
3.2.2 Global Omalizumab for Injection Revenue Market Share by Company (2020-2022)
3.3 Global Omalizumab for Injection Sale Price by Company
3.4 Key Manufacturers Omalizumab for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Omalizumab for Injection Product Location Distribution
3.4.2 Players Omalizumab for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Omalizumab for Injection by Geographic Region
4.1 World Historic Omalizumab for Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Omalizumab for Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Omalizumab for Injection Annual Revenue by Geographic Region
4.2 World Historic Omalizumab for Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Omalizumab for Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Omalizumab for Injection Annual Revenue by Country/Region
4.3 Americas Omalizumab for Injection Sales Growth
4.4 APAC Omalizumab for Injection Sales Growth
4.5 Europe Omalizumab for Injection Sales Growth
4.6 Middle East & Africa Omalizumab for Injection Sales Growth
5 Americas
5.1 Americas Omalizumab for Injection Sales by Country
5.1.1 Americas Omalizumab for Injection Sales by Country (2017-2022)
5.1.2 Americas Omalizumab for Injection Revenue by Country (2017-2022)
5.2 Americas Omalizumab for Injection Sales by Type
5.3 Americas Omalizumab for Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Omalizumab for Injection Sales by Region
6.1.1 APAC Omalizumab for Injection Sales by Region (2017-2022)
6.1.2 APAC Omalizumab for Injection Revenue by Region (2017-2022)
6.2 APAC Omalizumab for Injection Sales by Type
6.3 APAC Omalizumab for Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Omalizumab for Injection by Country
7.1.1 Europe Omalizumab for Injection Sales by Country (2017-2022)
7.1.2 Europe Omalizumab for Injection Revenue by Country (2017-2022)
7.2 Europe Omalizumab for Injection Sales by Type
7.3 Europe Omalizumab for Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Omalizumab for Injection by Country
8.1.1 Middle East & Africa Omalizumab for Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Omalizumab for Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Omalizumab for Injection Sales by Type
8.3 Middle East & Africa Omalizumab for Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Omalizumab for Injection
10.3 Manufacturing Process Analysis of Omalizumab for Injection
10.4 Industry Chain Structure of Omalizumab for Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Omalizumab for Injection Distributors
11.3 Omalizumab for Injection Customer
12 World Forecast Review for Omalizumab for Injection by Geographic Region
12.1 Global Omalizumab for Injection Market Size Forecast by Region
12.1.1 Global Omalizumab for Injection Forecast by Region (2023-2028)
12.1.2 Global Omalizumab for Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Omalizumab for Injection Forecast by Type
12.7 Global Omalizumab for Injection Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Omalizumab for Injection Product Offered
13.1.3 Roche Omalizumab for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
14 Research Findings and Conclusion
Table 1. Omalizumab for Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Omalizumab for Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Subcutaneous Powder For Injection
Table 4. Major Players of Subcutaneous Solution (150 mg/mL)
Table 5. Major Players of Subcutaneous Solution(75 mg/0.5 mL)
Table 6. Global Omalizumab for Injection Sales by Type (2017-2022) & (K Units)
Table 7. Global Omalizumab for Injection Sales Market Share by Type (2017-2022)
Table 8. Global Omalizumab for Injection Revenue by Type (2017-2022) & ($ million)
Table 9. Global Omalizumab for Injection Revenue Market Share by Type (2017-2022)
Table 10. Global Omalizumab for Injection Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Omalizumab for Injection Sales by Application (2017-2022) & (K Units)
Table 12. Global Omalizumab for Injection Sales Market Share by Application (2017-2022)
Table 13. Global Omalizumab for Injection Revenue by Application (2017-2022)
Table 14. Global Omalizumab for Injection Revenue Market Share by Application (2017-2022)
Table 15. Global Omalizumab for Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Omalizumab for Injection Sales by Company (2020-2022) & (K Units)
Table 17. Global Omalizumab for Injection Sales Market Share by Company (2020-2022)
Table 18. Global Omalizumab for Injection Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Omalizumab for Injection Revenue Market Share by Company (2020-2022)
Table 20. Global Omalizumab for Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Omalizumab for Injection Producing Area Distribution and Sales Area
Table 22. Players Omalizumab for Injection Products Offered
Table 23. Omalizumab for Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Omalizumab for Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Omalizumab for Injection Sales Market Share Geographic Region (2017-2022)
Table 28. Global Omalizumab for Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Omalizumab for Injection Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Omalizumab for Injection Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Omalizumab for Injection Sales Market Share by Country/Region (2017-2022)
Table 32. Global Omalizumab for Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Omalizumab for Injection Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Omalizumab for Injection Sales by Country (2017-2022) & (K Units)
Table 35. Americas Omalizumab for Injection Sales Market Share by Country (2017-2022)
Table 36. Americas Omalizumab for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Omalizumab for Injection Revenue Market Share by Country (2017-2022)
Table 38. Americas Omalizumab for Injection Sales by Type (2017-2022) & (K Units)
Table 39. Americas Omalizumab for Injection Sales Market Share by Type (2017-2022)
Table 40. Americas Omalizumab for Injection Sales by Application (2017-2022) & (K Units)
Table 41. Americas Omalizumab for Injection Sales Market Share by Application (2017-2022)
Table 42. APAC Omalizumab for Injection Sales by Region (2017-2022) & (K Units)
Table 43. APAC Omalizumab for Injection Sales Market Share by Region (2017-2022)
Table 44. APAC Omalizumab for Injection Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Omalizumab for Injection Revenue Market Share by Region (2017-2022)
Table 46. APAC Omalizumab for Injection Sales by Type (2017-2022) & (K Units)
Table 47. APAC Omalizumab for Injection Sales Market Share by Type (2017-2022)
Table 48. APAC Omalizumab for Injection Sales by Application (2017-2022) & (K Units)
Table 49. APAC Omalizumab for Injection Sales Market Share by Application (2017-2022)
Table 50. Europe Omalizumab for Injection Sales by Country (2017-2022) & (K Units)
Table 51. Europe Omalizumab for Injection Sales Market Share by Country (2017-2022)
Table 52. Europe Omalizumab for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Omalizumab for Injection Revenue Market Share by Country (2017-2022)
Table 54. Europe Omalizumab for Injection Sales by Type (2017-2022) & (K Units)
Table 55. Europe Omalizumab for Injection Sales Market Share by Type (2017-2022)
Table 56. Europe Omalizumab for Injection Sales by Application (2017-2022) & (K Units)
Table 57. Europe Omalizumab for Injection Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Omalizumab for Injection Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Omalizumab for Injection Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Omalizumab for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Omalizumab for Injection Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Omalizumab for Injection Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Omalizumab for Injection Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Omalizumab for Injection Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Omalizumab for Injection Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Omalizumab for Injection
Table 67. Key Market Challenges & Risks of Omalizumab for Injection
Table 68. Key Industry Trends of Omalizumab for Injection
Table 69. Omalizumab for Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Omalizumab for Injection Distributors List
Table 72. Omalizumab for Injection Customer List
Table 73. Global Omalizumab for Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Omalizumab for Injection Sales Market Forecast by Region
Table 75. Global Omalizumab for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Omalizumab for Injection Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Omalizumab for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Omalizumab for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Omalizumab for Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Omalizumab for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Omalizumab for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Omalizumab for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Omalizumab for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Omalizumab for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Omalizumab for Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Omalizumab for Injection Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Omalizumab for Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Omalizumab for Injection Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Omalizumab for Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Omalizumab for Injection Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Omalizumab for Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Omalizumab for Injection Revenue Market Share Forecast by Application (2023-2028)
Table 93. Roche Basic Information, Omalizumab for Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Roche Omalizumab for Injection Product Offered
Table 95. Roche Omalizumab for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Roche Main Business
Table 97. Roche Latest Developments
Table 98. Novartis Basic Information, Omalizumab for Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis Omalizumab for Injection Product Offered
Table 100. Novartis Omalizumab for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Novartis Main Business
Table 102. Novartis Latest Developments
List of Figures
Figure 1. Picture of Omalizumab for Injection
Figure 2. Omalizumab for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Omalizumab for Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Omalizumab for Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Omalizumab for Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Subcutaneous Powder For Injection
Figure 10. Product Picture of Subcutaneous Solution (150 mg/mL)
Figure 11. Product Picture of Subcutaneous Solution(75 mg/0.5 mL)
Figure 12. Global Omalizumab for Injection Sales Market Share by Type in 2021
Figure 13. Global Omalizumab for Injection Revenue Market Share by Type (2017-2022)
Figure 14. Omalizumab for Injection Consumed in Hospital
Figure 15. Global Omalizumab for Injection Market: Hospital (2017-2022) & (K Units)
Figure 16. Omalizumab for Injection Consumed in Clinic
Figure 17. Global Omalizumab for Injection Market: Clinic (2017-2022) & (K Units)
Figure 18. Global Omalizumab for Injection Sales Market Share by Application (2017-2022)
Figure 19. Global Omalizumab for Injection Revenue Market Share by Application in 2021
Figure 20. Omalizumab for Injection Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Omalizumab for Injection Revenue Market Share by Company in 2021
Figure 22. Global Omalizumab for Injection Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Omalizumab for Injection Revenue Market Share by Geographic Region in 2021
Figure 24. Global Omalizumab for Injection Sales Market Share by Region (2017-2022)
Figure 25. Global Omalizumab for Injection Revenue Market Share by Country/Region in 2021
Figure 26. Americas Omalizumab for Injection Sales 2017-2022 (K Units)
Figure 27. Americas Omalizumab for Injection Revenue 2017-2022 ($ Millions)
Figure 28. APAC Omalizumab for Injection Sales 2017-2022 (K Units)
Figure 29. APAC Omalizumab for Injection Revenue 2017-2022 ($ Millions)
Figure 30. Europe Omalizumab for Injection Sales 2017-2022 (K Units)
Figure 31. Europe Omalizumab for Injection Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Omalizumab for Injection Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Omalizumab for Injection Revenue 2017-2022 ($ Millions)
Figure 34. Americas Omalizumab for Injection Sales Market Share by Country in 2021
Figure 35. Americas Omalizumab for Injection Revenue Market Share by Country in 2021
Figure 36. United States Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Omalizumab for Injection Sales Market Share by Region in 2021
Figure 41. APAC Omalizumab for Injection Revenue Market Share by Regions in 2021
Figure 42. China Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Omalizumab for Injection Sales Market Share by Country in 2021
Figure 49. Europe Omalizumab for Injection Revenue Market Share by Country in 2021
Figure 50. Germany Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Omalizumab for Injection Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Omalizumab for Injection Revenue Market Share by Country in 2021
Figure 57. Egypt Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Omalizumab for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Omalizumab for Injection in 2021
Figure 63. Manufacturing Process Analysis of Omalizumab for Injection
Figure 64. Industry Chain Structure of Omalizumab for Injection
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
